SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $10,167,805,420 |
| Positions | 208 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Novartis AG (ADR) | NVS | ADR | $318,618,100 | 2,033,040 |
| Cisco Systems Inc. | CSCO | COM | $300,422,954 | 2,557,662 |
| Morgan Stanley | MS | COM | $295,482,478 | 1,413,521 |
| Johnson & Johnson | JNJ | COM | $279,132,521 | 1,099,077 |
| Citigroup Inc. | C | COM | $270,018,559 | 1,929,255 |
| JP Morgan Chase & Co. | JPM | COM | $265,392,705 | 810,780 |
| Merck & Co. Inc. | MRK | COM | $259,158,168 | 2,016,795 |
| Bank of America Corp. | BAC | COM | $247,054,927 | 4,335,818 |
| Duke Energy Corp. | DUK | COM | $244,731,344 | 1,933,412 |
| Johnson Controls International | JCI | COM | $244,213,790 | 1,671,438 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.